DURECT Ownership | Who Owns DURECT?
DURECT Ownership Summary
DURECT is owned by 21.18% institutional investors, 11.21% insiders, and 67.61% retail investors. Montchanin asset management is the largest institutional shareholder, holding 0.99% of DRRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.83% of its assets in DURECT shares.
DRRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | DURECT | 21.18% | 11.21% | 67.61% |
| Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
| Industry | Specialty & Generic Drug Manufacturers Stocks | 2774.71% | 11.85% | -2686.56% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Montchanin asset management | 301.85K | 0.99% | $389.00K |
| Regis management | 13.43K | 0.04% | $17.00K |
| Jane street group | - | - | - |
| International assets investment management | - | - | - |
| Cbiz investment advisory services | - | - | - |
| Xtx topco | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Montchanin asset management | 301.85K | 0.37% | $389.00K |
| Regis management | 13.43K | 0.01% | $17.00K |
| Jane street group | - | - | - |
| International assets investment management | - | - | - |
| Cbiz investment advisory services | - | - | - |
| Xtx topco | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Montchanin asset management | 301.85K | 0.37% | 31.75K |
| Regis management | 13.43K | 0.01% | - |
| Cbiz investment advisory services | - | - | -360.00 |
| International assets investment management | - | - | -15.30K |
| Xtx topco | - | - | -24.50K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jane street group | - | - | -39.20K |
| Xtx topco | - | - | -24.50K |
| International assets investment management | - | - | -15.30K |
| Cbiz investment advisory services | - | - | -360.00 |
| Regis management | 13.43K | 0.01% | - |
Sold Out
| Holder | Change |
|---|---|
| Cbiz investment advisory services | -360.00 |
| International assets investment management | -15.30K |
| Xtx topco | -24.50K |
| Jane street group | -39.20K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 39 | -15.22% | 6,574,350 | -3.70% | 21 | 4.35% | 11 | -38.89% | 10 | -16.67% |
| Dec 31, 2024 | 1 | - | 310,118 | 2.00% | - | 104.13% | 1 | - | - | - |
| Sep 30, 2024 | 1 | -50.00% | 304,032 | -3.57% | - | 92.49% | 1 | - | - | - |
| Jun 30, 2024 | 2 | - | 315,277 | 11.20% | 1 | 120.16% | 1 | - | - | - |
| Mar 31, 2024 | 2 | 100.00% | 283,526 | 2011.93% | - | 35419.37% | 1 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 879.76K | 2.83% | - |
| Vanguard US Total Market Shares ETF | 751.16K | 2.42% | - |
| Vanguard Institutional Extnd Mkt Idx Tr | 363.77K | 1.17% | - |
| Fidelity Extended Market Index | 171.94K | 0.55% | 3.06K |
| Fidelity Total Market Index | 51.36K | 0.17% | - |
| Fidelity Series Total Market Index | 41.37K | 0.13% | - |
| BlackRock Extended Equity Market K | 41.14K | 0.13% | -17.00 |
| Extended Equity Market Fund K | 40.70K | 0.13% | 125.00 |
| Spartan Extended Market Index Pool E | 31.62K | 0.10% | 1.47K |
| Spartan Extended Market Index Pool F | 31.62K | 0.10% | 1.47K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Dec 10, 2021 | Sussman Norman | Chief Medical Officer | Sell | $9.49K |
| Aug 18, 2022 | Robertson Judith J. | Buy | $8.00K | |
| Aug 17, 2022 | Robertson Judith J. | Buy | $6.91K | |
| Aug 12, 2022 | Maderis Gail J | Buy | $17.99K | |
| Aug 11, 2022 | Maderis Gail J | - | Buy | $17.32K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2023 Q2 | - | - |
| 2023 Q1 | - | - |
| 2022 Q3 | 6 | - |
DRRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools